Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 227 entries
Sorted by: Best Match Show Resources per page
Negro medical students in the United States.

Journal of the National Medical Association

BENT MJ.
PMID: 14850984
J Natl Med Assoc. 1951 Jul;43(4):275-7.

No abstract available.

Cite
BENT MJ. Negro medical students in the United States. J Natl Med Assoc. 1951;43(4):275-7
BENT, M. J. (1951). Negro medical students in the United States. Journal of the National Medical Association, 43(4), 275-7.
BENT, M J. "Negro medical students in the United States." Journal of the National Medical Association vol. 43,4 (1951): 275-7.
BENT MJ. Negro medical students in the United States. J Natl Med Assoc. 1951 Jul;43(4):275-7. PMID: 14850984; PMCID: PMC2616941.
Copy Download .nbib Format: NLM
Clinical signs and studies of the site of action of purified larkspur alkaloid, methyllycaconitine, administered parenterally to calves.

The Canadian veterinary journal = La revue veterinaire canadienne

Nation PN, Benn MH, Roth SH, Wilkens JL.
PMID: 17422179
Can Vet J. 1982 Sep;23(9):264-6.

The purified diterpenoid alkaloid, methyllycaconitine was isolated from Delphinium brownii and injected intravenously into beef calves in order to observe the clinical signs. Following injection and depending upon dosage, calves showed a variety of signs; agitation, respiratory difficulty and...

Cite
Nation PN, Benn MH, Roth SH, et al. Clinical signs and studies of the site of action of purified larkspur alkaloid, methyllycaconitine, administered parenterally to calves. Can Vet J. 1982;23(9):264-6
Nation, P. N., Benn, M. H., Roth, S. H., & Wilkens, J. L. (1982). Clinical signs and studies of the site of action of purified larkspur alkaloid, methyllycaconitine, administered parenterally to calves. The Canadian veterinary journal = La revue veterinaire canadienne, 23(9), 264-6.
Nation, P N, et al. "Clinical signs and studies of the site of action of purified larkspur alkaloid, methyllycaconitine, administered parenterally to calves." The Canadian veterinary journal = La revue veterinaire canadienne vol. 23,9 (1982): 264-6.
Nation PN, Benn MH, Roth SH, Wilkens JL. Clinical signs and studies of the site of action of purified larkspur alkaloid, methyllycaconitine, administered parenterally to calves. Can Vet J. 1982 Sep;23(9):264-6. PMID: 17422179; PMCID: PMC1790203.
Copy Download .nbib Format: NLM
Emerging antibody-based HER2 (ErbB-2/neu) therapeutics.

Breast disease

Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC.
PMID: 15687597
Breast Dis. 2000;11:113-24. doi: 10.3233/bd-1999-11110.

Targeting HER2(ErbB-2/neu) overexpressing tumor cells to selectively deliver anticancer agents and thereby reduce host toxicity represents a rational and emerging strategy for the treatment of breast and other epithelial cancers. The extracellular domain of the HER2 receptor tyrosine kinase...

Cite
Krauss WC, Park JW, Kirpotin DB, et al. Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. Breast Dis. 2000;11:113-24doi: 10.3233/bd-1999-11110.
Krauss, W. C., Park, J. W., Kirpotin, D. B., Hong, K., & Benz, C. C. (2000). Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. Breast disease, 11113-24. https://doi.org/10.3233/bd-1999-11110
Krauss, W C, et al. "Emerging antibody-based HER2 (ErbB-2/neu) therapeutics." Breast disease vol. 11 (2000): 113-24. doi: https://doi.org/10.3233/bd-1999-11110
Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC. Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. Breast Dis. 2000;11:113-24. doi: 10.3233/bd-1999-11110. PMID: 15687597.
Copy Download .nbib Format: NLM
QTLMAS 2009: simulated dataset.

BMC proceedings

Coster A, Bastiaansen JW, Calus MP, Maliepaard C, Bink MC.
PMID: 20380757
BMC Proc. 2010 Mar 31;4:S3. doi: 10.1186/1753-6561-4-S1-S3.

BACKGROUND: The simulation of the data for the QTLMAS 2009 Workshop is described. Objective was to simulate observations from a growth curve which was influenced by a number of QTL.RESULTS: The data consisted of markers, phenotypes and pedigree. Genotypes...

Cite
Coster A, Bastiaansen JW, Calus MP, et al. QTLMAS 2009: simulated dataset. BMC Proc. 2010;4:S3doi: 10.1186/1753-6561-4-S1-S3.
Coster, A., Bastiaansen, J. W., Calus, M. P., Maliepaard, C., & Bink, M. C. (2010). QTLMAS 2009: simulated dataset. BMC proceedings, 4S3. https://doi.org/10.1186/1753-6561-4-S1-S3
Coster, Albart, et al. "QTLMAS 2009: simulated dataset." BMC proceedings vol. 4 (2010): S3. doi: https://doi.org/10.1186/1753-6561-4-S1-S3
Coster A, Bastiaansen JW, Calus MP, Maliepaard C, Bink MC. QTLMAS 2009: simulated dataset. BMC Proc. 2010 Mar 31;4:S3. doi: 10.1186/1753-6561-4-S1-S3. PMID: 20380757; PMCID: PMC2857845.
Copy Download .nbib Format: NLM
The Use and Abuse of the Relationship between Doctor and Patient in the Practice of Psychotherapy.

Proceedings of the Royal Society of Medicine

Bell MC.
PMID: 19983324
Proc R Soc Med. 1923;16:12-20.

No abstract available.

Cite
Bell MC. The Use and Abuse of the Relationship between Doctor and Patient in the Practice of Psychotherapy. Proc R Soc Med. 1923;16:12-20
Bell, M. C. (1923). The Use and Abuse of the Relationship between Doctor and Patient in the Practice of Psychotherapy. Proceedings of the Royal Society of Medicine, 1612-20.
Bell, M C. "The Use and Abuse of the Relationship between Doctor and Patient in the Practice of Psychotherapy." Proceedings of the Royal Society of Medicine vol. 16 (1923): 12-20.
Bell MC. The Use and Abuse of the Relationship between Doctor and Patient in the Practice of Psychotherapy. Proc R Soc Med. 1923;16:12-20. PMID: 19983324; PMCID: PMC2102953.
Copy Download .nbib Format: NLM
Synthetic extracellular matrix supports healing of mucogingival surgery donor sites.

Tissue engineering

Martin G, Béné MC, Mole N, Penaud J, Faure GC, Miller NA.
PMID: 19877906
Tissue Eng. 1995;1(3):279-88. doi: 10.1089/ten.1995.1.279.

Palatal donor sites are commonly used in periodontal surgery. Their healing speed determines the patient's comfort. This may be enhanced by the use of collagen sponges, supplemented with various components of the extracellular matrix, which display chemotactic properties and...

Cite
Martin G, Béné MC, Mole N, et al. Synthetic extracellular matrix supports healing of mucogingival surgery donor sites. Tissue Eng. 1995;1(3):279-88doi: 10.1089/ten.1995.1.279.
Martin, G., Béné, M. C., Mole, N., Penaud, J., Faure, G. C., & Miller, N. A. (1995). Synthetic extracellular matrix supports healing of mucogingival surgery donor sites. Tissue engineering, 1(3), 279-88. https://doi.org/10.1089/ten.1995.1.279
Martin, G, et al. "Synthetic extracellular matrix supports healing of mucogingival surgery donor sites." Tissue engineering vol. 1,3 (1995): 279-88. doi: https://doi.org/10.1089/ten.1995.1.279
Martin G, Béné MC, Mole N, Penaud J, Faure GC, Miller NA. Synthetic extracellular matrix supports healing of mucogingival surgery donor sites. Tissue Eng. 1995;1(3):279-88. doi: 10.1089/ten.1995.1.279. PMID: 19877906.
Copy Download .nbib Format: NLM
p53 Adenovirus as Gene Therapy for Ovarian Cancer.

Methods in molecular medicine

Carroll JL, Michael Mathis J, Bell MC, Santoso JT.
PMID: 21340840
Methods Mol Med. 2001;39:783-92. doi: 10.1385/1-59259-071-3:783.

Ovarian cancer arises from the accumulation of mutations in multiple combinations of genes (1). The most extensively studied tumor suppressor gene in solid tumors is p53, a 53-kD nuclear phosphoprotein that binds DNA. The p53 gene product plays a...

Cite
Carroll JL, Michael Mathis J, Bell MC, et al. p53 Adenovirus as Gene Therapy for Ovarian Cancer. Methods Mol Med. 2001;39:783-92doi: 10.1385/1-59259-071-3:783.
Carroll, J. L., Michael Mathis, J., Bell, M. C., & Santoso, J. T. (2001). p53 Adenovirus as Gene Therapy for Ovarian Cancer. Methods in molecular medicine, 39783-92. https://doi.org/10.1385/1-59259-071-3:783
Carroll, J L, et al. "p53 Adenovirus as Gene Therapy for Ovarian Cancer." Methods in molecular medicine vol. 39 (2001): 783-92. doi: https://doi.org/10.1385/1-59259-071-3:783
Carroll JL, Michael Mathis J, Bell MC, Santoso JT. p53 Adenovirus as Gene Therapy for Ovarian Cancer. Methods Mol Med. 2001;39:783-92. doi: 10.1385/1-59259-071-3:783. PMID: 21340840.
Copy Download .nbib Format: NLM
Sulphanilamide in Scarlet Fever.

British medical journal

Benn EC.
PMID: 20782659
Br Med J. 1939 Sep 23;2(4107):644-6. doi: 10.1136/bmj.2.4107.644.

No abstract available.

Cite
Benn EC. Sulphanilamide in Scarlet Fever. Br Med J. 1939;2(4107):644-6doi: 10.1136/bmj.2.4107.644.
Benn, E. C. (1939). Sulphanilamide in Scarlet Fever. British medical journal, 2(4107), 644-6. https://doi.org/10.1136/bmj.2.4107.644
Benn, E C. "Sulphanilamide in Scarlet Fever." British medical journal vol. 2,4107 (1939): 644-6. doi: https://doi.org/10.1136/bmj.2.4107.644
Benn EC. Sulphanilamide in Scarlet Fever. Br Med J. 1939 Sep 23;2(4107):644-6. doi: 10.1136/bmj.2.4107.644. PMID: 20782659; PMCID: PMC2178218.
Copy Download .nbib Format: NLM
How do adult neurons survive?.

Discovery medicine

Benn SC, Woolf CJ.
PMID: 20704894
Discov Med. 2005 Jun;5(27):309-18.

Extract: Apoptotic cell death, also known as cell suicide or programmed cell death, is a series of intracellular biochemical steps that lead to a cell's controlled but inevitable death. Apoptosis plays a crucial role in the normal development of...

Cite
Benn SC, Woolf CJ. How do adult neurons survive?. Discov Med. 2005;5(27):309-18
Benn, S. C., & Woolf, C. J. (2005). How do adult neurons survive?. Discovery medicine, 5(27), 309-18.
Benn, Susanna C, and Woolf, Clifford J. "How do adult neurons survive?." Discovery medicine vol. 5,27 (2005): 309-18.
Benn SC, Woolf CJ. How do adult neurons survive?. Discov Med. 2005 Jun;5(27):309-18. PMID: 20704894.
Copy Download .nbib Format: NLM
Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign).

Clinical ophthalmology (Auckland, N.Z.)

Chen E, Brown DM, Benz MS, Fish RH, Wong TP, Kim RY, Major JC.
PMID: 21060664
Clin Ophthalmol. 2010 Oct 21;4:1151-8. doi: 10.2147/OPTH.S14257.

PURPOSE: While the long-term incidence of hydroxychloroquine (HCQ) retinopathy is low, there remains no definitive clinical screening test to recognize HCQ toxicity before ophthalmoscopic fundus changes or visual symptoms. Patients receiving HCQ were evaluated with spectral domain optical coherence...

Cite
Chen E, Brown DM, Benz MS, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign). Clin Ophthalmol. 2010;4:1151-8doi: 10.2147/OPTH.S14257.
Chen, E., Brown, D. M., Benz, M. S., Fish, R. H., Wong, T. P., Kim, R. Y., & Major, J. C. (2010). Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign). Clinical ophthalmology (Auckland, N.Z.), 41151-8. https://doi.org/10.2147/OPTH.S14257
Chen, Eric, et al. "Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign)." Clinical ophthalmology (Auckland, N.Z.) vol. 4 (2010): 1151-8. doi: https://doi.org/10.2147/OPTH.S14257
Chen E, Brown DM, Benz MS, Fish RH, Wong TP, Kim RY, Major JC. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign). Clin Ophthalmol. 2010 Oct 21;4:1151-8. doi: 10.2147/OPTH.S14257. PMID: 21060664; PMCID: PMC2964950.
Copy Download .nbib Format: NLM
A short-pulse X-ray beamline for spectroscopy and scattering.

Journal of synchrotron radiation

Reininger R, Dufresne EM, Borland M, Beno MA, Young L, Evans PG.
PMID: 25178012
J Synchrotron Radiat. 2014 Sep;21:1194-9. doi: 10.1107/S1600577514012302. Epub 2014 Jul 31.

Experimental facilities for picosecond X-ray spectroscopy and scattering based on RF deflection of stored electron beams face a series of optical design challenges. Beamlines designed around such a source enable time-resolved diffraction, spectroscopy and imaging studies in chemical, condensed...

Cite
Reininger R, Dufresne EM, Borland M, et al. A short-pulse X-ray beamline for spectroscopy and scattering. J Synchrotron Radiat. 2014;21:1194-9doi: 10.1107/S1600577514012302.
Reininger, R., Dufresne, E. M., Borland, M., Beno, M. A., Young, L., & Evans, P. G. (2014). A short-pulse X-ray beamline for spectroscopy and scattering. Journal of synchrotron radiation, 211194-9. https://doi.org/10.1107/S1600577514012302
Reininger, R, et al. "A short-pulse X-ray beamline for spectroscopy and scattering." Journal of synchrotron radiation vol. 21 (2014): 1194-9. doi: https://doi.org/10.1107/S1600577514012302
Reininger R, Dufresne EM, Borland M, Beno MA, Young L, Evans PG. A short-pulse X-ray beamline for spectroscopy and scattering. J Synchrotron Radiat. 2014 Sep;21:1194-9. doi: 10.1107/S1600577514012302. Epub 2014 Jul 31. PMID: 25178012.
Copy Download .nbib Format: NLM
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Cell

Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van't Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA, Benz CC, Perou CM, Stuart JM.
PMID: 25109877
Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 07.

Recent genomic analyses of pathologically defined tumor types identify "within-a-tissue" disease subtypes. However, the extent to which genomic signatures are shared across tissues is still unclear. We performed an integrative analysis using five genome-wide platforms and one proteomic platform...

Cite
Hoadley KA, Yau C, Wolf DM, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014;158(4):929-944doi: 10.1016/j.cell.2014.06.049.
Hoadley, K. A., Yau, C., Wolf, D. M., Cherniack, A. D., Tamborero, D., Ng, S., Leiserson, M. D. M., Niu, B., McLellan, M. D., Uzunangelov, V., Zhang, J., Kandoth, C., Akbani, R., Shen, H., Omberg, L., Chu, A., Margolin, A. A., Van't Veer, L. J., Lopez-Bigas, N., Laird, P. W., Raphael, B. J., Ding, L., Robertson, A. G., Byers, L. A., Mills, G. B., Weinstein, J. N., Van Waes, C., Chen, Z., Collisson, E. A., Benz, C. C., Perou, C. M., & Stuart, J. M. (2014). Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell, 158(4), 929-944. https://doi.org/10.1016/j.cell.2014.06.049
Hoadley, Katherine A, et al. "Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin." Cell vol. 158,4 (2014): 929-944. doi: https://doi.org/10.1016/j.cell.2014.06.049
Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van't Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA, Benz CC, Perou CM, Stuart JM. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 07. PMID: 25109877; PMCID: PMC4152462.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 227 entries